Skip to main content
Clinical Trials/ACTRN12619001652167
ACTRN12619001652167
Completed
未知

The relations between the level of Mu-opioid receptor (µORs) and postoperative analgesic use in patients undergoing septoplasty: a randomized, prospective trial.

MUZAFFER GENCER0 sites120 target enrollmentNovember 26, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
MUZAFFER GENCER
Enrollment
120
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

As the level of the µ-Opioid receptor (µORs) increased in the study groups, the duration of the second analgesic requirement increased. Patients with a high level of µORs experienced less analgesic need in the post-op period. In this study, we found that the efficacy of opioid analgesic agents was higher and the need for additional analgesics was lower in patients with higher µ-Opioid receptor (µORs) levels. This effect was thought to be increased by antidepressant effect. Opioid analgesics combined with steroids also reduced need for second analgesic agents.

Registry
who.int
Start Date
November 26, 2019
End Date
January 28, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
MUZAFFER GENCER

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing septoplasty

Exclusion Criteria

  • Patients with surgical planning except septoplasty

Outcomes

Primary Outcomes

Not specified

Similar Trials